Using a sound-wave skin device to monitor eczema and psoriasis
Tests whether a sound-wave skin scanner can track eczema and psoriasis severity in adults.
Key facts
- Who runs it
- University of Edinburgh
- Where
- Edinburgh, United KingdomSee the site
- Trial code
- Registry title
- Evidencing Vibroacoustic Sensing for Inflammatory Skin Disease Monitoring
- Status
- Not yet recruiting
- People taking part
- 20 people, planned
- Started
- 1 Oct 2026
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- Vibroacoustic sensing device
- Record updated
- 29 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with moderate or severe eczema or psoriasis who are about to start phototherapy. A skin-scanning device that uses sound waves is tested alongside normal skin checks.
- Age
- Over 18 and under 75 years old.
- Sex
- All sexes can join.
- Disease stage
- Moderate or severe inflammatory skin disease, mainly eczema or psoriasis.
- Earlier treatment
- Phototherapy must be planned to start within the next 21 days. People whose phototherapy has already started cannot join.
Main reasons for not taking part
- Cannot give informed consent
- Phototherapy already started
- Conditions that slow healing or disturb the measurements, such as diabetes, weakened immune system, blood-thinning medicine, extensive scarring or pregnancy
- Known allergy to Parylene-C, the material that touches the skin
- Not willing to use contraception during the study, if able to have children
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Over 18 and under 75 years old
- Able to give informed consent
- Diagnosed with a moderate or severe inflammatory skin condition (in particular, eczema or psoriasis)
- Scheduled to begin phototherapy within the next 21 days
- Able to attend the clinic for their weekly treatment sessions
- No known hypersensitivity to the material that will come into contact with skin during the study (i.e., Parylene-C)
- Where there is childbearing potential , willing to use effective contraception throughout the study
Who cannot take part
- Patients with comorbidities or conditions that might slow down healing or confound measurements at this stage (e.g., diabetes, immunosuppressed, on blood thinning medication, with extensive scarring, or pregnant)
- Patients with known hypersensitivity to the material that will come into contact with skin during the study (i.e., Parylene-C)
- Age below 18 or over 75
- Unable to provide informed consent
- Patients whose phototherapy treatment has already started
- Patients who are not willing to use contraception throughout the study and are of childbearing potential
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United Kingdom
- Lauriston BuildingEdinburgh, United KingdomContact: Richard Weller, MB BS MDNot yet recruiting
About the trial
What the trial wants to find out
Over 300 million people around the world struggle with skin conditions like eczema and psoriasis, which cause ongoing discomfort and emotional stress. In the UK, these conditions are diagnosed by doctors looking at the skin to assess the severity of the disease, but delays in seeing specialists contribute to long waiting times in the NHS. To tackle these problems, the investigators have created a device that safely uses sound waves to measure skin properties, like stiffness and moisture. Unlike just looking, this device gives clear, data-based insights into skin health, which the investigators hope will enable us to accurately measure disease severity without the need to wait for a dermatologist appointment. This should speed up specialist referrals and allow us to tailor treatment options more effectively, earlier on.
Read full original descriptionShow less
In our study, we want to prove that these sound wave measurements match up with disease severity and treatment success in eczema and psoriasis cases. We'll compare the results with those from dermatologists.
We are looking for 20 volunteers with eczema or psoriasis who are about to start treatment. Volunteers will be scanned with our device alongside their regular skin examinations. We'll gather some extra information through questions and photos (optional), but no additional treatments or painful procedures are involved.
The group in the trial
- Study participants - all
This group will be the only group in the study as this is a comparator between device and clinician
Treatment: Vibroacoustic sensing device
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evidencing Vibroacoustic Sensing for Inflammatory Skin Disease Monitoring
- Plain-language title
- Using a sound-wave skin device to monitor eczema and psoriasisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07846813, who can take part
- Record updated
- 29 September 2026